Glow-in-the-dark dye could help surgeons remove brain tumors more precisely

NCT ID NCT07438860

First seen Mar 07, 2026 · Last updated May 22, 2026 · Updated 13 times

Summary

This early-phase study tests whether a dye called SBK2-ICG can help surgeons see the exact edges of brain tumors during surgery. About 12 adults with suspected or confirmed malignant brain tumors will receive the dye before their standard surgery. The goal is to find the best dose that makes tumor borders glow, so surgeons can remove as much tumor as possible while keeping healthy brain tissue safe.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Premier Health Neuroscience Institute

    Dayton, Ohio, 45409, United States

    Contact

    Contact

  • University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center

    Cleveland, Ohio, 44106, United States

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.